Functional Impact of Acute Respiratory Viral Infections in Older Adults
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University Hospital, Grenoble
- Study ID
- NCT07388173
- Status
- Recruiting
Conditions
- Respiratory Infections in Old Age
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The prevention of infectious diseases in older adults remains a major public health challenge, as acute respiratory infections are a leading cause of hospitalisation, mortality, and functional decline worldwide. Immunosenescence and environmental exposures increase susceptibility to infection and reduce vaccine effectiveness in this population. Respiratory viruses, including influenza, SARS-CoV-2, respiratory syncytial virus, and human metapneumovirus, account for a substantial share of this burden, much of which is vaccine-preventable. However, their impact on functional decline and recovery in older adults remains insufficiently characterized. This international study aims to assess the effect of hospitalization for major respiratory viral infections on loss of autonomy in individuals aged 60 years and older, to inform targeted prevention and vaccination strategies.
Key Dates
- Start date
- Jan 15, 2026
- Status verified
- May 2026
- Primary completion
- Jan 15, 2028
- Completion
- Jun 15, 2028
Study Design
- Enrollment
- 1,600 participants (estimated)
Primary Outcome Measure
Evolution of Functional Dependency assessed by Activities of Daily Living (ADL) Score [ Time Frame: Baseline, at hospital discharge, 3 months after discharge, and 6 months after discharge. ]
Central Contacts
- Gaetan GAVAZZI, MD,PhD0033(0)476766760
- Saber TOUATI, PhD0033(0)476765805
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Rochester School of Medicine, Infectious Diseases Unit | Rochester | New York | 14642 | Edward Walsh, MD PhD |